Clinical Investigation on the Outcome of Episealer Talus Post-operation

Status Recruiting

Clinical Trial Summary

This is a retrospective, observational, single-arm, multi-centre, post-market clinical investigation designed to verify clinical performance and safety of Episealer Talus post-operation for treatment of focal osteochondral defects on the talus bone in the ankle. This retrospective investigation aims to collect data from patients with focal osteochondral defects treated with Episealer Talus, to provide insight on the potential benefit of Episealer Talus in the treatment of focal osteochondral defects. The aim for the clinical investigation is to collect data from approximately 25 adult subjects who were treated for focal osteochondral defect with Episealer Talus implant in 6 clinics (Sweden and Germany) since January 2020, when the devices were CE-marked. The data collected for each subject will include demographics and data generated in relation to the surgery itself and the post-surgery phases including e.g. focal defect grade and position, collected through medical record review. Each subject will also be asked to complete a set of QoL questionnaires (SEFAS, FAOS and VAS).

Clinical Trial Description

This is a retrospective, observational, single-arm, multi-centre, post-market clinical investigation designed to verify clinical performance and safety of Episealer Talus post-operation for treatment of focal OCDs. The overall clinical investigation is based on the patient's reported outcome (PROs) from OCD patients previously treated with Episealer Talus implant after January 2020. In total approximately 25 adult subjects, male or female, from 6 clinics (Sweden and Germany) will be included in the investigation. Subjects will be identified by the investigational site team through medical record review and/or site knowing the subjects from performing the implantation after January 2020. Following collection of the subject´s signed informed consent, subject demographics, health- and surgery-related data will be collected from the subjects' medical records. Therefore, only one visit is planned for each subject during the clinical investigation. The performance variables relate to quality of life, and all subjects will be asked to fill in three questionnaires (SEFAS, FAOS and VAS). The overall duration of the investigation is estimated to be 4 months, including a 1 month recruitment period. Each subject is estimated to spend approximately 1-2 hour for completing the informed consent and completing the questionnaires. Subject´s participation in the clinical investigation will be terminated once the questionnaires have been completed and the site team considers all data collected for the subject. ;

Study Design

Related Conditions & MeSH terms

Osteochondral Defect

Clinical Trial Details

NCT number	NCT06225674
Study type	Observational
Source	Episurf Medical Inc.
Contact	Fredrik Zetterberg
Phone	+46 70-839 62 33
Email	fredrik.zetterberg@episurf.com
Status	Recruiting
Phase
Start date	November 6, 2023
Completion date	March 6, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06078072` - Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions
Terminated	`NCT00945399` - Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions	Phase 3
Completed	`NCT03385642` - Follow-Up Study Evaluating the Long Term Outcome of ChondroMimetic in the Treatment of Osteochondral Defects in the Knee
Recruiting	`NCT05124613` - The Impact of Covid-19 on Patients Waiting for Knee Surgery
Not yet recruiting	`NCT06216756` - Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee	N/A
Recruiting	`NCT04236492` - Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts
Recruiting	`NCT03625180` - An Observational, Prospective Study of Patients With Chondral and/or Osteochondral Defects of the Knee Treated With NAMIC
Recruiting	`NCT03696394` - A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects	N/A
Recruiting	`NCT04364334` - Knee Registry (Knieregister)
Completed	`NCT03452098` - Post-Operative Rehabilitation of Knee Osteochondral Defect: A Case Series
Terminated	`NCT03036878` - ReNu™ Marrow Stimulation Augmentation	N/A
Recruiting	`NCT03777735` - Human Bone Graft for Fixation of Osteochondral Defects in the Knee Joint
Recruiting	`NCT03908931` - Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral Defects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms